# REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

> **NCT00271154** · NA · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 684 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT

## Key facts

- **NCT ID:** NCT00271154
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-10
- **Final completion:** 2011-11
- **Target enrollment:** 684 (ACTUAL)
- **Last updated:** 2012-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271154, "REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00271154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*